Altimmune Inc
(ALT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,520 | -39,171 | -46,425 | -11,087 | -3,441 |
| Depreciation Amortization | 387 | 25,243 | 36,059 | 135 | 142 |
| Income taxes - deferred | N/A | -6,150 | -2,617 | 0 | 62 |
| Accounts receivable | 2,441 | 344 | -1,949 | 131 | -1,067 |
| Accounts payable and accrued liabilities | -355 | 243 | -2,624 | 854 | 130 |
| Other Working Capital | 1,761 | 6,980 | -8,691 | 1,116 | -505 |
| Other Operating Activity | 6,684 | 3,121 | 6,033 | 2,498 | 1,464 |
| Operating Cash Flow | $-9,602 | $-9,389 | $-20,214 | $-6,353 | $-3,216 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -28,257 | 0 | N/A | N/A | N/A |
| PPE Investments | -1 | -961 | -105 | -125 | -79 |
| Net Acquisitions | N/A | N/A | 13,685 | N/A | N/A |
| Purchase Sale Intangibles | -28 | -40 | -54 | -96 | N/A |
| Other Investing Activity | -28 | -40 | 146 | -96 | 0 |
| Investing Cash Flow | $-28,286 | $-1,001 | $13,726 | $-221 | $-79 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 1 | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -750 |
| Common Stock Issued | 12,699 | 37,426 | 17 | 2 | 973 |
| Other Financing Activity | -167 | -4,936 | 15,825 | 4,980 | 0 |
| Financing Cash Flow | $12,532 | $32,490 | $15,841 | $4,983 | $223 |
| Exchange Rate Effect | N/A | -50 | 74 | -172 | -2 |
| Beginning Cash Position | 34,353 | 12,304 | 2,876 | 4,639 | 18,643 |
| End Cash Position | 8,997 | 34,353 | 12,304 | 2,876 | 15,570 |
| Net Cash Flow | $-25,356 | $22,050 | $9,428 | $-1,763 | $-3,074 |
| Free Cash Flow | |||||
| Operating Cash Flow | -9,602 | -9,389 | -20,214 | -6,353 | -3,216 |
| Capital Expenditure | -1 | -975 | -112 | -125 | -87 |
| Free Cash Flow | -9,603 | -10,364 | -20,327 | -6,478 | -3,303 |